Discovery and structural characterization of monkeypox virus methyltransferase VP39 inhibitors reveal similarities to SARS-CoV-2 nsp14 methyltransferase

被引:0
|
作者
Jan Silhan
Martin Klima
Tomas Otava
Petr Skvara
Dominika Chalupska
Karel Chalupsky
Jan Kozic
Radim Nencka
Evzen Boura
机构
[1] Institute of Organic Chemistry and Biochemistry AS CR,Faculty of Food and Biochemical Technology
[2] University of Chemistry and Technology,undefined
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Monkeypox is a disease with pandemic potential. It is caused by the monkeypox virus (MPXV), a double-stranded DNA virus from the Poxviridae family, that replicates in the cytoplasm and must encode for its own RNA processing machinery including the capping machinery. Here, we present crystal structures of its 2′-O-RNA methyltransferase (MTase) VP39 in complex with the pan-MTase inhibitor sinefungin and a series of inhibitors that were discovered based on it. A comparison of this 2′-O-RNA MTase with enzymes from unrelated single-stranded RNA viruses (SARS-CoV-2 and Zika) reveals a conserved sinefungin binding mode, implicating that a single inhibitor could be used against unrelated viral families. Indeed, several of our inhibitors such as TO507 also inhibit the coronaviral nsp14 MTase.
引用
收藏
相关论文
共 50 条
  • [1] Discovery and structural characterization of monkeypox virus methyltransferase VP39 inhibitors reveal similarities to SARS-CoV-2 nsp14 methyltransferase
    Silhan, Jan
    Klima, Martin
    Otava, Tomas
    Skvara, Petr
    Chalupska, Dominika
    Chalupsky, Karel
    Kozic, Jan
    Nencka, Radim
    Boura, Evzen
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [2] Rational Design of Highly Potent SARS-CoV-2 nsp14 Methyltransferase Inhibitors
    Stefek, Milan
    Chalupska, Dominika
    Chalupsky, Karel
    Zgarbova, Michala
    Dvorakova, Alexandra
    Krafcikova, Petra
    Li, Alice Shi Ming
    Sala, Michal
    Dejmek, Milan
    Otava, Tomas
    Chaloupecka, Ema
    Kozak, Jaroslav
    Kozic, Jan
    Vedadi, Masoud
    Weber, Jan
    Mertlikova-Kaiserova, Helena
    Nencka, Radim
    ACS OMEGA, 2023, 8 (30): : 27410 - 27418
  • [3] Structure-Based Discovery of Inhibitors of the SARS-CoV-2 Nsp14 N7-Methyltransferase
    Singh, Isha
    Li, Fengling
    Fink, Elissa A.
    Chau, Irene
    Li, Alice
    Rodriguez-Hernandez, Annia
    Glenn, Isabella
    Zapatero-Belinchon, Francisco J.
    Rodriguez, M. Luis
    Devkota, Kanchan
    Deng, Zhijie
    White, Kris
    Wan, Xiaobo
    Tolmachova, Nataliya A.
    Moroz, Yurii S.
    Kaniskan, H. Umit
    Ott, Melanie
    Garcia-Sastre, Adolfo
    Jin, Jian
    Fujimori, Danica Galonic
    Irwin, John J.
    Vedadi, Masoud
    Shoichet, Brian K.
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (12) : 7785 - 7803
  • [4] Discovery of highly potent SARS-CoV-2 nsp14 methyltransferase inhibitors based on adenosine 5′-carboxamides
    Kocek, Hugo
    Chalupska, Dominika
    Dejmek, Milan
    Dvorakova, Alexandra
    Zgarbova, Michala
    Sala, Michal
    Chalupsky, Karel
    Krafcikova, Petra
    Otava, Tomas
    Drexler, Matus
    Prochazkova, Eliska
    Klepetarova, Blanka
    Stefek, Milan
    Kozic, Jan
    Mertlikova-Kaiserova, Helena
    Boura, Evzen
    Weber, Jan
    Nencka, Radim
    RSC MEDICINAL CHEMISTRY, 2024, 15 (10): : 3469 - 3476
  • [5] Discovery of SARS-CoV-2 Nsp14 and Nsp16 Methyltransferase Inhibitors by High-Throughput Virtual Screening
    Bobrovs, Raitis
    Kanepe, Iveta
    Narvaiss, Nauris
    Patetko, Liene
    Kalnins, Gints
    Sisovs, Mihails
    Bula, Anna L.
    Grinberga, Solveiga
    Boroduskis, Martins
    Ramata-Stunda, Anna
    Rostoks, Nils
    Jirgensons, Aigars
    Tars, Kaspars
    Jaudzems, Kristaps
    PHARMACEUTICALS, 2021, 14 (12)
  • [6] Inhibitors of mpox VP39 2′-O methyltransferase efficiently inhibit the monkeypox virus
    Zgarbova, Michala
    Otava, Tomas
    Silhan, Jan
    Nencka, Radim
    Weber, Jan
    Boura, Evzen
    ANTIVIRAL RESEARCH, 2023, 218
  • [7] 3-(Adenosylthio)benzoic Acid Derivatives as SARS-CoV-2 Nsp14 Methyltransferase Inhibitors
    Bobileva, Olga
    Bobrovs, Raitis
    Sirma, Evelina Elva
    Kanepe, Iveta
    Bula, Anna L.
    Patetko, Liene
    Ramata-Stunda, Anna
    Grinberga, Solveiga
    Jirgensons, Aigars
    Jaudzems, Kristaps
    MOLECULES, 2023, 28 (02):
  • [8] Structure-Based Virtual Screening for Methyltransferase Inhibitors of SARS-CoV-2 nsp14 and nsp16
    Wu, Kejue
    Guo, Yinfeng
    Xu, Tiefeng
    Huang, Weifeng
    Guo, Deyin
    Cao, Liu
    Lei, Jinping
    MOLECULES, 2024, 29 (10):
  • [9] A High-Throughput Screening Pipeline to Identify Methyltransferase and Exonuclease Inhibitors of SARS-CoV-2 NSP14
    Hanson, Quinlin
    Hu, Xin
    Pal, Sourav
    Recabo, Katlin
    Ye, Lin
    Poon, Ivy
    Denson, John-Paul
    Messing, Simon
    Shen, Min
    Wilson, Kelli M.
    Zakharov, Alexey
    Esposito, Dominic
    Martinez, Natalia J.
    BIOCHEMISTRY, 2025, 64 (02) : 419 - 431
  • [10] The Structure-Based Design of SARS-CoV-2 nsp14 Methyltransferase Ligands Yields Nanomolar Inhibitors
    Otava, Tomas
    Sala, Michal
    Li, Fengling
    Fanfrlik, Jindrich
    Devkota, Kanchan
    Perveen, Sumera
    Chau, Irene
    Pakarian, Paknoosh
    Hobza, Pavel
    Vedadi, Masoud
    Boura, Evzen
    Nencka, Radim
    ACS INFECTIOUS DISEASES, 2021, 7 (08): : 2214 - 2220